PDL BioPharma, Inc. Cash and Short Term Investments

Cash and Short Term Investments of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash and Short Term Investments growth rates and interactive chart. Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities. Cash and short term investments are considered very liquid assets.


Highlights and Quick Summary

  • Cash and Short Term Investments for the quarter ending June 29, 2020 was $105 Million (a -15.99% decrease compared to previous quarter)
  • Year-over-year quarterly Cash and Short Term Investments decreased by -64.17%
  • Annual Cash and Short Term Investments for 2019 was $193 Million (a -50.97% decrease from previous year)
  • Annual Cash and Short Term Investments for 2018 was $395 Million (a -25.84% decrease from previous year)
  • Annual Cash and Short Term Investments for 2017 was $532 Million (a 119.75% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash and Short Term Investments of PDL BioPharma, Inc.

Most recent Cash and Short Term Investmentsof PDLI including historical data for past 10 years.

Interactive Chart of Cash and Short Term Investments of PDL BioPharma, Inc.

PDL BioPharma, Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $105.45 $125.51
2019 $168.98 $294.27 $284.94 $366.32 $193.45
2018 $394.59 $400.98 $395.65 $405.08 $394.59
2017 $532.11 $516.49 $435.32 $409.32 $532.11
2016 $242.14 $189.58 $221.79 $291.96 $242.14
2015 $220.35 $229.68 $294.09 $418.92 $220.35
2014 $293.69 $284.45 $217.77 $337.59 $293.69
2013 $99.54 $326.46 $278.85 $207.21 $99.54
2012 $168.69 $180.37 $228.32 $187.38 $168.69
2011 $210.85 $194.98 $198.29 $160.4 $210.85
2010 $246.23 $227.19 $223.69 $246.23

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.